Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Diamond BiofundTPE:6901 -3.93%16 Receivables Turnover is 0.00 as of Dec. 2025. GuruFocus rates TPE:6901 with a GF Score™ of 16/100. The stock has 2 warning signs investors should review. Among 529 Asset Management companies, Diamond Biofund ranks worse than 189035.73% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Diamond Biofund's Revenue for the
three
months ended in Dec. 2025 was NT$0.00 Mil. Diamond Biofund's average Accounts Receivable for the
three
months ended in Dec. 2025 was NT$0.00 Mil.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Diamond Biofund Receivables Turnover Related Terms
Diamond Biofund Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Diamond Biofund's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6901 vs BLK, BX, KKR: Receivables Turnover Comparison
For the Asset Management subindustry, Diamond Biofund's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diamond Biofund Receivables Turnover vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Diamond Biofund's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Diamond Biofund's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diamond Biofund (TPE:6901) has a Receivables Turnover of 0.00 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Diamond Biofund and its competitors. According to the industry distribution chart, Diamond Biofund ranks #999999 out of 529 companies in the Asset Management industry.
Is Diamond Biofund's Receivables Turnover too high?
Diamond Biofund's current Receivables Turnover is 0.00. Based on the distribution chart, Diamond Biofund ranks #999999 out of 529 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Diamond Biofund has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's Receivables Turnover compare to BLK and BX?
According to the Asset Management industry distribution chart, Diamond Biofund ranks #999999 out of 529 companies for Receivables Turnover. This places Diamond Biofund in the lower half of its industry. The industry median Receivables Turnover is 7.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for an Asset Management company?
The median Receivables Turnover among Asset Management companies is 7.89, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Diamond Biofund and its competitors. For the Asset Management industry, the median Receivables Turnover is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diamond Biofund's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Diamond Biofund's overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current Receivables Turnover is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
16GF Score
Get the complete analysis for TPE:6901
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6901 has been successfully added to your 
